IRIS
RIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.822
AS - Asia 4.933
EU - Europa 3.603
SA - Sud America 1.141
AF - Africa 160
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.647
SG - Singapore 2.245
CN - Cina 1.230
BR - Brasile 1.021
SE - Svezia 803
HK - Hong Kong 679
RU - Federazione Russa 552
IT - Italia 543
DE - Germania 483
VN - Vietnam 310
GB - Regno Unito 277
UA - Ucraina 265
FI - Finlandia 234
FR - Francia 124
IN - India 107
CA - Canada 94
ID - Indonesia 62
BE - Belgio 59
CI - Costa d'Avorio 59
JP - Giappone 56
MX - Messico 53
AR - Argentina 49
BD - Bangladesh 48
IE - Irlanda 41
NL - Olanda 40
PL - Polonia 39
IQ - Iraq 36
ZA - Sudafrica 32
CZ - Repubblica Ceca 30
AT - Austria 28
ES - Italia 27
LT - Lituania 24
TR - Turchia 24
CO - Colombia 19
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 16
MA - Marocco 15
PK - Pakistan 15
EC - Ecuador 13
VE - Venezuela 13
KE - Kenya 12
SA - Arabia Saudita 12
EG - Egitto 10
IR - Iran 9
PE - Perù 9
KR - Corea 8
PH - Filippine 8
JO - Giordania 7
UY - Uruguay 7
IL - Israele 6
TN - Tunisia 6
AU - Australia 5
CL - Cile 5
PA - Panama 5
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
RS - Serbia 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
HT - Haiti 3
KW - Kuwait 3
LY - Libia 3
MK - Macedonia 3
MY - Malesia 3
NO - Norvegia 3
PY - Paraguay 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GH - Ghana 2
GM - Gambi 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
ZM - Zambia 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
Totale 22.649
Salva come PNG Salva come JPEG
Città #
Fairfield 1.541
Ashburn 1.358
Singapore 1.182
Chandler 1.140
Woodbridge 1.071
Houston 670
Hong Kong 653
Seattle 640
Nyköping 596
Jacksonville 582
Cambridge 561
Wilmington 509
Ann Arbor 482
Beijing 391
New York 279
Lawrence 213
Roxbury 212
Los Angeles 210
Nanjing 204
Bari 172
Dallas 171
Des Moines 133
Munich 130
Inglewood 111
Princeton 105
Boardman 92
Ho Chi Minh City 90
São Paulo 83
Brooklyn 81
Buffalo 74
Helsinki 68
London 63
San Diego 63
Abidjan 59
Brussels 59
Nanchang 57
Chicago 55
Santa Clara 54
Hanoi 52
Shenyang 52
Jakarta 50
Rome 46
Moscow 44
Dearborn 42
Dong Ket 40
Dublin 39
Denver 38
Jiaxing 38
Montreal 37
Council Bluffs 35
Tokyo 35
The Dalles 34
Columbus 32
Frankfurt am Main 31
Hebei 31
Stockholm 30
Nuremberg 28
Brno 27
Leawood 27
Pune 27
Toronto 27
Marseille 26
Phoenix 26
Tianjin 26
Guangzhou 24
Washington 24
Falkenstein 23
Turku 23
Belo Horizonte 22
Chennai 22
Orem 22
Warsaw 22
Baghdad 21
Johannesburg 21
San Francisco 21
San Jose 21
Changsha 20
Curitiba 20
Grafing 20
Mexico City 20
Paris 20
Salt Lake City 20
Amsterdam 19
Haiphong 19
Milan 19
Poplar 19
Augusta 18
Brasília 18
Jinan 18
Manchester 17
Osaka 17
Rio de Janeiro 17
Tampa 17
Tashkent 17
Boston 16
Porto Alegre 16
Zhengzhou 16
Redwood City 15
Atlanta 14
Kunming 14
Totale 15.826
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 274
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 218
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 200
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 188
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 177
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 169
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 167
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 166
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 165
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 163
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 160
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 158
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 156
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 155
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 155
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 152
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 151
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 151
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 150
Neutropenia and G-CSF in lymphoproliferative diseases 150
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 148
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 146
Identify multiple myeloma stem cells: Utopia? 146
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 141
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 139
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 138
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 138
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 137
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 133
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 131
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials 131
Bortezomib treatment modulates autophagy in multiple myeloma 128
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 127
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials 127
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 126
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 126
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 122
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 121
Endothelial cells in the bone marrow of patients with multiple myeloma 120
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 120
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis 120
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 120
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 119
Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? 119
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis 119
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents 119
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 118
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 117
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 117
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 116
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts 115
Fibrinogen apheresis in the treatment of peripheral arterial disease 115
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis 115
Angiogenesis and Antiangiogenesis in Multiple Myeloma 115
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 115
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response 114
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 114
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 114
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 113
Could multiple myeloma VEGF modify the systemic microcirculation? 112
Circulating miRNA markers show promise as new prognosticators for multiple myeloma 112
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial 111
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 111
Delayed complete remission in a patient with multiple myeloma 111
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 110
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas 109
A weekly infusion of bortezomib reduces peripheral neuropathy 109
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 109
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma 108
Circulating cell adhesion molecules are increased in hypertensive left ventricular hypertrophy 107
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression 107
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? 106
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 105
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 105
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma 105
Angiogenesis in multiple myeloma 104
Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia 103
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial 103
HIF-1a of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target 101
null 101
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases 100
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 100
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study 99
Efficacy and safety of once weekly bortezomib in multiple myeloma patients 99
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. 98
Angiogenesi e progressione tumorale nel melanoma 97
A VEGF-dependent autocrine loop on endothelial cells pomotes angiogenesis and progression in multiple myeloma 97
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients 97
In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane 97
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma 96
Can a decreasing ultrafiltration profile affect the dyalitic dose administered ? 96
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 96
TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically 95
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 95
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 95
Effects of severe hypertension on soluble cellular adhesion molecule levels 94
Angiogenesis and progression in human melanoma 94
Cancer-related coagulopathy (Trousseau's syndrome): Review of the literature and experience of a single center of internal medicine 94
Cross-talk between hematopoiesis and angiogenesis signaling pathways 94
Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women 93
Totale 12.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.539 0 0 0 0 0 190 205 200 182 335 254 173
2021/20221.640 153 203 17 52 63 106 92 84 95 122 272 381
2022/20232.877 379 299 184 280 329 421 21 304 528 22 53 57
2023/20241.179 100 196 71 60 104 328 60 71 7 22 30 130
2024/20254.481 127 96 322 204 122 412 421 432 186 272 694 1.193
2025/20264.834 1.384 401 526 973 1.081 469 0 0 0 0 0 0
Totale 23.374